About Us
Senior Management
Board of Directors
Contact Us
Pipeline
Lorigerlimab (PD-1 × CTLA-4)
MGC026 (B7-H3 ADC)
MGC028 (ADAM9 ADC)
MGD024 (CD123 × CD3)
MGC030
Technology
Platforms
Publications
Patients
Clinical Trials
Expanded Access
Resources
Investors
Investor Relations
Press Releases
Events and Presentations
Corporate Governance
Senior Management
Board of Directors
Committee Composition
Contact the Board
Financials & Filings
SEC Filings
Quarterly Results
Key Metrics
Stock Information
Historic Stock Lookup
Investment Calculator
Analyst Coverage
Ownership Profile
Investor FAQs
Publications
Contact Investor Relations
Join Our Team
Current Openings
Employee Benefits
corporate-responsibility
Home
About Us
corporate-responsibility
